In the news release, New Wave: Welcomes Iman Nevab, Homeopathic Research Expert to the
New Wave: Welcomes Iman Navab, Homeopathic Research Expert to the Scientific Advisory Board
New Wave Holdings Announces New Scientific Advisory Board Member
With his extensive knowledge in homeopathy and six years of academic studies in natural medicine at a prominent Canadian college under his belt,
"It is with great pleasure that we are formally introducing our newest member to the advisory team," said
In addition to his expertise in natural medicine, he is also the founder of Dynamise, a company that focuses on the development and creation of natural skincare and health products that are backed by science and research.
"It is an honour to be a member of New Wave's scientific advisory board. I strongly believe that science of mycology and herbology has great medicinal benefits for the wellbeing of mankind, which must be explored diligently. As
ABOUT
Investors interested in connecting with
The CSE has not in any way passed on the merits of the Acquisition, and neither has approved nor disapproved the contents of this press release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
FORWARD-LOOKING INFORMATION DISCLAIMER
Certain statements contained in this news release may constitute forward–looking information, including but not limited to, applicable regulatory approval in connection with the Acquisition, the closing of the Acquisition, expansion of operations, size and quality of future tournaments and projections regarding attendance at future events. Forward–looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward–looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward–looking information. The Company's actual results could differ materially from those anticipated in this forward–looking information as a result of competitive factors and competition for investment opportunities, challenges relating to operations in international markets, transaction execution risk, changes to the Company's strategic growth plans, and other factors, many of which are beyond the control of the Company. The Company believes that the expectations reflected in the forward–looking information are reasonable based on current expectations and potential investment pipeline, but no assurance can be given that these expectations will prove to be correct and such forward–looking information should not be unduly relied upon. Any forward–looking information contained in this news release represents the Company's expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward–looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
View original content to download multimedia:http://www.prnewswire.com/news-releases/new-wave-welcomes-iman-navab-homeopathic-research-expert-to-the-scientific-advisory-board-301212701.html
SOURCE
© Canada Newswire, source